Experience

WELLTH HOLDINGS

• United States
• Business Consulting and Services
• 1 - 100 Employee

• Senior Director

  • Sep 2019 - Present

  At WELLTH Holdings, our mission is to "build brand capital" by buying, investing and growing high-potential consumer brands that have a health or wellness consumer benefit . In 2019, WELLTH acquired WINESTIQ. WINESTIQ instantly removes sulfite-preservatives from red, white, rosé, and sparkling wines from both a single-glass and full-bottle for a healthier wine experience! Although sulfite-preservatives prolong shelf life, they also cause issues such as Headache, Stuffiness… Show more At WELLTH Holdings, our mission is to "build brand capital" by buying, investing and growing high-potential consumer brands that have a health or wellness consumer benefit . In 2019, WELLTH acquired WINESTIQ. WINESTIQ instantly removes sulfite-preservatives from red, white, rosé, and sparkling wines from both a single-glass and full-bottle for a healthier wine experience! Although sulfite-preservatives prolong shelf life, they also cause issues such as Headache, Stuffiness, Flushed, Nasal Congestion, Itchiness, Upset Stomach AND the ability to Live Preservative-Free. WINESTIQ supports wine-lovers on their journey to healthier living. Show less At WELLTH Holdings, our mission is to "build brand capital" by buying, investing and growing high-potential consumer brands that have a health or wellness consumer benefit . In 2019, WELLTH acquired WINESTIQ. WINESTIQ instantly removes sulfite-preservatives from red, white, rosé, and sparkling wines from both a single-glass and full-bottle for a healthier wine experience! Although sulfite-preservatives prolong shelf life, they also cause issues such as Headache, Stuffiness… Show more At WELLTH Holdings, our mission is to "build brand capital" by buying, investing and growing high-potential consumer brands that have a health or wellness consumer benefit . In 2019, WELLTH acquired WINESTIQ. WINESTIQ instantly removes sulfite-preservatives from red, white, rosé, and sparkling wines from both a single-glass and full-bottle for a healthier wine experience! Although sulfite-preservatives prolong shelf life, they also cause issues such as Headache, Stuffiness, Flushed, Nasal Congestion, Itchiness, Upset Stomach AND the ability to Live Preservative-Free. WINESTIQ supports wine-lovers on their journey to healthier living. Show less



YourBevCo, LLC

• Consumer Goods

• President & CEO

  • Sep 2013 - Present

  YourBevCo, LLC is a beverage device company developing a pipeline of innovative, disruptive consumer devices that safely and effectively remove problematic ingredients from beverages that are known to cause allergic or sensitivity reactions. YourBevCo, LLC is a beverage device company developing a pipeline of innovative, disruptive consumer devices that safely and effectively remove problematic ingredients from beverages that are known to cause allergic or sensitivity reactions.



2 Blue Consulting LLC

• President & Owner

  • Jan 2012 - Present

  Providing expert consultancy to the pharmaceutical, biotechnology and scientific academic community Providing expert consultancy to the pharmaceutical, biotechnology and scientific academic community



Accuronix Therapeutics, Inc.

• Research Services

• Consultant VP, R&D

  • Mar 2015 - Mar 2018

  Accuronix Therapeutics is a drug discovery and development company that is developing novel oncology therapies that selectively target cancer cells and deliver cytotoxic drug payloads, thereby increasing efficacy and reducing toxicity risk to healthy cells. Accuronix Therapeutics is a drug discovery and development company that is developing novel oncology therapies that selectively target cancer cells and deliver cytotoxic drug payloads, thereby increasing efficacy and reducing toxicity risk to healthy cells.



BioGenerator

• United States
• Biotechnology Research
• 1 - 100 Employee

• Entrepreneur in Residence

  • Aug 2011 - Mar 2016

  BioGenerator is a privately funded non-profit organization with a mission to promote the growth of the bioscience industry in the St. Louis region. My role is to use my extensive pharmaceutical experience to assist with the creation and growth of new life science companies that have received or are strong candidates for BioGenerator funding. BioGenerator is a privately funded non-profit organization with a mission to promote the growth of the bioscience industry in the St. Louis region. My role is to use my extensive pharmaceutical experience to assist with the creation and growth of new life science companies that have received or are strong candidates for BioGenerator funding.



Epigenetx, LLC

• United States
• Pharmaceutical Manufacturing

• President & CEO

  • Jan 2014 - Jan 2016

  Epigenetx is a drug discovery and development company using a platform technology developed by leading computational medicinal chemists to discover and develop isoform selective histone deacetylase (HDAC) inhibitors for a range of disease indications. Epigenetx is a drug discovery and development company using a platform technology developed by leading computational medicinal chemists to discover and develop isoform selective histone deacetylase (HDAC) inhibitors for a range of disease indications.



Tansna Therapeutics Inc.

• Vice President, Research & Development

  • Jul 2012 - Dec 2015

  Tansna Therapeutics is a drug discovery and development company that is developing novel oral anticonvulsant drugs for the treatment of refractory epilepsy. Tansna Therapeutics is a drug discovery and development company that is developing novel oral anticonvulsant drugs for the treatment of refractory epilepsy.



Companion Pharma Inc.

• Corporate Director & Secretary, Board of Directors

  • Feb 2012 - Apr 2014

  CPI is an animal health product development company that will offer a range of safe, effective, pet friendly, veterinary approved medicines for use under prescription in companion animals. CPI is an animal health product development company that will offer a range of safe, effective, pet friendly, veterinary approved medicines for use under prescription in companion animals.



Pfizer

• Events Services
• 1 - 100 Employee

• Associate Research Fellow & Research Project Leader, Indications Discovery Unit

  • 2007 - 2011

  A Research Project Leader for atherosclerosis, dyslipidemia, diabetes & obesity projects and leader of the obesity and diabetes laboratory in the Indications Discovery drug repositioning unit. Responsible for identifying and clinically validating through to phase 2 PoC, high value opportunities for additional indications for the active and failed development compounds in the Pfizer portfolio, through internal collaboration across the organization and external collaboration with leading academic… Show more A Research Project Leader for atherosclerosis, dyslipidemia, diabetes & obesity projects and leader of the obesity and diabetes laboratory in the Indications Discovery drug repositioning unit. Responsible for identifying and clinically validating through to phase 2 PoC, high value opportunities for additional indications for the active and failed development compounds in the Pfizer portfolio, through internal collaboration across the organization and external collaboration with leading academic medical centers and CROs.

• Senior Principal Scientist, CVMED group, St. Louis

  • 2003 - 2007

  Project Leader for Hypertension and Metabolic disease teams and leader of Metabolic Hypertension in vivo pharmacology laboratory. Responsible for identifying and validating through to candidate nomination for clinical development, novel drug targets for a range of cardiovascular diseases (hypertension, thrombosis, diabetes, obesity)

• Team Leader & Senior Scientist

  • 1992 - 2003

  Scientist (in vivo pharmacology) and team leader for numerous drug target teams focused on multiple cardiovascular disease areas (thrombosis, vascular inflammation & PVD, skeletal muscle and cardiac metabolism, hypertension)